APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Influenza Drugs and Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Influenza Drugs and Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174002670326 December 2025199 pages

Choose your research edition.

Industry ResearchInfluenza Drugs and Vaccines Industry Research Report 2026148 pages · $2,950 USDIndustry Growth & TrendsGlobal Influenza Drugs and Vaccines Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Influenza Drugs and Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Influenza Drugs and Vaccines Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Influenza Drugs and Vaccines Market Analysis and Forecast 2026-2032210 pages · $4,950 USD

Market perspective

The global Influenza Drugs and Vaccines market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Influenza Drugs and Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Influenza Drugs and Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Influenza Drugs and Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Influenza Drugs and Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Influenza Drugs and Vaccines include CSL, Alvogen, AstraZeneca, BioCryst Pharmaceuticals, Bristol Myers Squibb, Celgene, Emergent Biosolutions, GlaxoSmithKline and Hulan Bio, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Influenza Drugs and Vaccines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Influenza Drugs and Vaccines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Influenza Drugs and Vaccines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Influenza Drugs and Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.

Influenza Drugs and Vaccines Segment by Company

CSL

Alvogen

AstraZeneca

BioCryst Pharmaceuticals

Bristol Myers Squibb

Celgene

Emergent Biosolutions

GlaxoSmithKline

Hulan Bio

Protein Sciences Corporation

Seqirus

Serum Institute of India

Viatris

Beike Bio

Bayer

Pfizer

Jiangsu GDK

Sinovac

Eli Lilly

Roche

Novartis

Sanofi

Changchun Institute of Biological

Influenza Drugs and Vaccines Segment by Type

Influenza Drugs

Influenza Vaccines

Influenza Drugs and Vaccines Segment by Application

Retail Pharmacy

Online Pharmacy

Hospital Pharmacy

Influenza Drugs and Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Influenza Drugs and Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Influenza Drugs and Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Influenza Drugs and Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Influenza Drugs and Vaccines market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Influenza Drugs and Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Influenza Drugs and Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Influenza Drugs and Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Influenza Drugs and Vaccines Industry Trends Table 2. Influenza Drugs and Vaccines Industry Drivers Table 3. Influenza Drugs and Vaccines Industry Opportunities and Challenges Table 4. Influenza Drugs and Vaccines Industry Restraints Table 5. Global Influenza Drugs and Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Influenza Drugs and Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Influenza Drugs and Vaccines Sales by Manufacturers (Tons) & (2021-2026) Table 8. Global Influenza Drugs and Vaccines Sales Market Share by Manufacturers Table 9. Global Influenza Drugs and Vaccines Average Sales Price (US$/Kg) of Manufacturers (2021-2026) Table 10. Global Influenza Drugs and Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Influenza Drugs and Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Influenza Drugs and Vaccines Manufacturers, Product Type & Application Table 13. Global Influenza Drugs and Vaccines Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Influenza Drugs and Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Influenza Drugs Table 17. Major Manufacturers of Influenza Vaccines Table 18. Global Influenza Drugs and Vaccines Sales by Type 2021 VS 2025 VS 2032 (Tons) Table 19. Global Influenza Drugs and Vaccines Sales by Type (2021-2026) & (Tons) Table 20. Global Influenza Drugs and Vaccines Sales by Type (2027-2032) & (Tons) Table 21. Global Influenza Drugs and Vaccines Sales Market Share by Type (2021-2026) Table 22. Global Influenza Drugs and Vaccines Sales Market Share by Type (2027-2032) Table 23. Global Influenza Drugs and Vaccines Revenue by Type 2021 VS 2025 VS 2032 (Tons) Table 24. Global Influenza Drugs and Vaccines Revenue by Type (2021-2026) & (Tons) Table 25. Global Influenza Drugs and Vaccines Revenue by Type (2027-2032) & (Tons) Table 26. Global Influenza Drugs and Vaccines Revenue Market Share by Type (2021-2026) Table 27. Global Influenza Drugs and Vaccines Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Retail Pharmacy Table 29. Major Manufacturers of Online Pharmacy Table 30. Major Manufacturers of Hospital Pharmacy Table 31. Global Influenza Drugs and Vaccines Sales by Application 2021 VS 2025 VS 2032 (Tons) Table 32. Global Influenza Drugs and Vaccines Sales by Application (2021-2026) & (Tons) Table 33. Global Influenza Drugs and Vaccines Sales by Application (2027-2032) & (Tons) Table 34. Global Influenza Drugs and Vaccines Sales Market Share by Application (2021-2026) Table 35. Global Influenza Drugs and Vaccines Sales Market Share by Application (2027-2032) Table 36. Global Influenza Drugs and Vaccines Revenue by Application 2021 VS 2025 VS 2032 (Tons) Table 37. Global Influenza Drugs and Vaccines Revenue by Application (2021-2026) & (Tons) Table 38. Global Influenza Drugs and Vaccines Revenue by Application (2027-2032) & (Tons) Table 39. Global Influenza Drugs and Vaccines Revenue Market Share by Application (2021-2026) Table 40. Global Influenza Drugs and Vaccines Revenue Market Share by Application (2027-2032) Table 41. Global Influenza Drugs and Vaccines Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 42. Global Influenza Drugs and Vaccines Sales by Region (2021-2026) & (Tons) Table 43. Global Influenza Drugs and Vaccines Sales Market Share by Region (2021-2026) Table 44. Global Influenza Drugs and Vaccines Sales Forecasted by Region (2027-2032) & (Tons) Table 45. Global Influenza Drugs and Vaccines Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Influenza Drugs and Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 47. North America Influenza Drugs and Vaccines Sales by Country (2021-2026) & (Tons) Table 48. North America Influenza Drugs and Vaccines Sales by Country (2027-2032) & (Tons) Table 49. Europe Influenza Drugs and Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 50. Europe Influenza Drugs and Vaccines Sales by Country (2021-2026) & (Tons) Table 51. Europe Influenza Drugs and Vaccines Sales by Country (2027-2032) & (Tons) Table 52. Asia Pacific Influenza Drugs and Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 53. Asia Pacific Influenza Drugs and Vaccines Sales by Country (2021-2026) & (Tons) Table 54. Asia Pacific Influenza Drugs and Vaccines Sales by Country (2027-2032) & (Tons) Table 55. South America, Middle East and Africa Influenza Drugs and Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 56. South America, Middle East and Africa Influenza Drugs and Vaccines Sales by Country (2021-2026) & (Tons) Table 57. South America, Middle East and Africa Influenza Drugs and Vaccines Sales by Country (2027-2032) & (Tons) Table 58. Global Influenza Drugs and Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Influenza Drugs and Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Influenza Drugs and Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Influenza Drugs and Vaccines Revenue Market Share by Region (2021-2026) Table 62. Global Influenza Drugs and Vaccines Revenue Market Share by Region (2027-2032) Table 63. CSL Company Information Table 64. CSL Business Overview Table 65. CSL Influenza Drugs and Vaccines Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. CSL Influenza Drugs and Vaccines Product Portfolio Table 67. CSL Recent Development Table 68. Alvogen Company Information Table 69. Alvogen Business Overview Table 70. Alvogen Influenza Drugs and Vaccines Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Alvogen Influenza Drugs and Vaccines Product Portfolio Table 72. Alvogen Recent Development Table 73. AstraZeneca Company Information Table 74. AstraZeneca Business Overview Table 75. AstraZeneca Influenza Drugs and Vaccines Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. AstraZeneca Influenza Drugs and Vaccines Product Portfolio Table 77. AstraZeneca Recent Development Table 78. BioCryst Pharmaceuticals Company Information Table 79. BioCryst Pharmaceuticals Business Overview Table 80. BioCryst Pharmaceuticals Influenza Drugs and Vaccines Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. BioCryst Pharmaceuticals Influenza Drugs and Vaccines Product Portfolio Table 82. BioCryst Pharmaceuticals Recent Development Table 83. Bristol Myers Squibb Company Information Table 84. Bristol Myers Squibb Business Overview Table 85. Bristol Myers Squibb Influenza Drugs and Vaccines Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Bristol Myers Squibb Influenza Drugs and Vaccines Product Portfolio Table 87. Bristol Myers Squibb Recent Development Table 88. Celgene Company Information Table 89. Celgene Business Overview Table 90. Celgene Influenza Drugs and Vaccines Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Celgene Influenza Drugs and Vaccines Product Portfolio Table 92. Celgene Recent Development Table 93. Emergent Biosolutions Company Information Table 94. Emergent Biosolutions Business Overview Table 95. Emergent Biosolutions Influenza Drugs and Vaccines Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Emergent Biosolutions Influenza Drugs and Vaccines Product Portfolio Table 97. Emergent Biosolutions Recent Development Table 98. GlaxoSmithKline Company Information Table 99. GlaxoSmithKline Business Overview Table 100. GlaxoSmithKline Influenza Drugs and Vaccines Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. GlaxoSmithKline Influenza Drugs and Vaccines Product Portfolio Table 102. GlaxoSmithKline Recent Development Table 103. Hulan Bio Company Information Table 104. Hulan Bio Business Overview Table 105. Hulan Bio Influenza Drugs and Vaccines Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Hulan Bio Influenza Drugs and Vaccines Product Portfolio Table 107. Hulan Bio Recent Development Table 108. Protein Sciences Corporation Company Information Table 109. Protein Sciences Corporation Business Overview Table 110. Protein Sciences Corporation Influenza Drugs and Vaccines Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Protein Sciences Corporation Influenza Drugs and Vaccines Product Portfolio Table 112. Protein Sciences Corporation Recent Development Table 113. Seqirus Company Information Table 114. Seqirus Business Overview Table 115. Seqirus Influenza Drugs and Vaccines Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Seqirus Influenza Drugs and Vaccines Product Portfolio Table 117. Seqirus Recent Development Table 118. Serum Institute of India Company Information Table 119. Serum Institute of India Business Overview Table 120. Serum Institute of India Influenza Drugs and Vaccines Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Serum Institute of India Influenza Drugs and Vaccines Product Portfolio Table 122. Serum Institute of India Recent Development Table 123. Viatris Company Information Table 124. Viatris Business Overview Table 125. Viatris Influenza Drugs and Vaccines Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Viatris Influenza Drugs and Vaccines Product Portfolio Table 127. Viatris Recent Development Table 128. Beike Bio Company Information Table 129. Beike Bio Business Overview Table 130. Beike Bio Influenza Drugs and Vaccines Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Beike Bio Influenza Drugs and Vaccines Product Portfolio Table 132. Beike Bio Recent Development Table 133. Bayer Company Information Table 134. Bayer Business Overview Table 135. Bayer Influenza Drugs and Vaccines Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Bayer Influenza Drugs and Vaccines Product Portfolio Table 137. Bayer Recent Development Table 138. Pfizer Company Information Table 139. Pfizer Business Overview Table 140. Pfizer Influenza Drugs and Vaccines Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Pfizer Influenza Drugs and Vaccines Product Portfolio Table 142. Pfizer Recent Development Table 143. Jiangsu GDK Company Information Table 144. Jiangsu GDK Business Overview Table 145. Jiangsu GDK Influenza Drugs and Vaccines Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. Jiangsu GDK Influenza Drugs and Vaccines Product Portfolio Table 147. Jiangsu GDK Recent Development Table 148. Sinovac Company Information Table 149. Sinovac Business Overview Table 150. Sinovac Influenza Drugs and Vaccines Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 151. Sinovac Influenza Drugs and Vaccines Product Portfolio Table 152. Sinovac Recent Development Table 153. Eli Lilly Company Information Table 154. Eli Lilly Business Overview Table 155. Eli Lilly Influenza Drugs and Vaccines Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 156. Eli Lilly Influenza Drugs and Vaccines Product Portfolio Table 157. Eli Lilly Recent Development Table 158. Roche Company Information Table 159. Roche Business Overview Table 160. Roche Influenza Drugs and Vaccines Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 161. Roche Influenza Drugs and Vaccines Product Portfolio Table 162. Roche Recent Development Table 163. Novartis Company Information Table 164. Novartis Business Overview Table 165. Novartis Influenza Drugs and Vaccines Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 166. Novartis Influenza Drugs and Vaccines Product Portfolio Table 167. Novartis Recent Development Table 168. Sanofi Company Information Table 169. Sanofi Business Overview Table 170. Sanofi Influenza Drugs and Vaccines Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 171. Sanofi Influenza Drugs and Vaccines Product Portfolio Table 172. Sanofi Recent Development Table 173. Changchun Institute of Biological Company Information Table 174. Changchun Institute of Biological Business Overview Table 175. Changchun Institute of Biological Influenza Drugs and Vaccines Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 176. Changchun Institute of Biological Influenza Drugs and Vaccines Product Portfolio Table 177. Changchun Institute of Biological Recent Development Table 178. Key Raw Materials Table 179. Raw Materials Key Suppliers Table 180. Influenza Drugs and Vaccines Distributors List Table 181. Influenza Drugs and Vaccines Customers List Table 182. Research Programs/Design for This Report Table 183. Authors List of This Report Table 184. Secondary Sources Table 185. Primary Sources List of Figures Figure 1. Influenza Drugs and Vaccines Product Image Figure 2. Global Influenza Drugs and Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Influenza Drugs and Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Influenza Drugs and Vaccines Sales (2021-2032) & (Tons) Figure 5. Global Influenza Drugs and Vaccines Average Price (US$/Kg) & (2021-2032) Figure 6. Global Top 5 and 10 Influenza Drugs and Vaccines Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Influenza Drugs Image Figure 9. Influenza Vaccines Image Figure 10. Global Influenza Drugs and Vaccines Sales by Type (2021 VS 2025 VS 2032) & (Tons) Figure 11. Global Influenza Drugs and Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Influenza Drugs and Vaccines Sales Market Share by Type (2021-2032) Figure 13. Global Influenza Drugs and Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (Tons) Figure 14. Global Influenza Drugs and Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Influenza Drugs and Vaccines Revenue Market Share by Type (2021-2032) Figure 16. Retail Pharmacy Image Figure 17. Online Pharmacy Image Figure 18. Hospital Pharmacy Image Figure 19. Global Influenza Drugs and Vaccines Sales by Application (2021 VS 2025 VS 2032) & (Tons) Figure 20. Global Influenza Drugs and Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Influenza Drugs and Vaccines Sales Market Share by Application (2021-2032) Figure 22. Global Influenza Drugs and Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (Tons) Figure 23. Global Influenza Drugs and Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Influenza Drugs and Vaccines Revenue Market Share by Application (2021-2032) Figure 25. North America Influenza Drugs and Vaccines Sales and Growth Rate (2021-2032) & (Tons) Figure 26. North America Influenza Drugs and Vaccines Sales Market Share by Country (2021-2032) Figure 27. U.S. Influenza Drugs and Vaccines Sales and Growth Rate (2021-2032) & (Tons) Figure 28. Canada Influenza Drugs and Vaccines Sales and Growth Rate (2021-2032) & (Tons) Figure 29. Mexico Influenza Drugs and Vaccines Sales and Growth Rate (2021-2032) & (Tons) Figure 30. Europe Influenza Drugs and Vaccines Sales and Growth Rate (2021-2032) & (Tons) Figure 31. Europe Influenza Drugs and Vaccines Sales Market Share by Country (2021-2032) Figure 32. Germany Influenza Drugs and Vaccines Sales and Growth Rate (2021-2032) & (Tons) Figure 33. France Influenza Drugs and Vaccines Sales and Growth Rate (2021-2032) & (Tons) Figure 34. U.K. Influenza Drugs and Vaccines Sales and Growth Rate (2021-2032) & (Tons) Figure 35. Italy Influenza Drugs and Vaccines Sales and Growth Rate (2021-2032) & (Tons) Figure 36. Netherlands Influenza Drugs and Vaccines Sales and Growth Rate (2021-2032) & (Tons) Figure 37. Asia Pacific Influenza Drugs and Vaccines Sales and Growth Rate (2021-2032) & (Tons) Figure 38. Asia Pacific Influenza Drugs and Vaccines Sales Market Share by Country (2021-2032) Figure 39. China Influenza Drugs and Vaccines Sales and Growth Rate (2021-2032) & (Tons) Figure 40. Japan Influenza Drugs and Vaccines Sales and Growth Rate (2021-2032) & (Tons) Figure 41. South Korea Influenza Drugs and Vaccines Sales and Growth Rate (2021-2032) & (Tons) Figure 42. Southeast Asia Influenza Drugs and Vaccines Sales and Growth Rate (2021-2032) & (Tons) Figure 43. India Influenza Drugs and Vaccines Sales and Growth Rate (2021-2032) & (Tons) Figure 44. Australia Influenza Drugs and Vaccines Sales and Growth Rate (2021-2032) & (Tons) Figure 45. South America, Middle East and Africa Influenza Drugs and Vaccines Sales and Growth Rate (2021-2032) & (Tons) Figure 46. South America, Middle East and Africa Influenza Drugs and Vaccines Sales Market Share by Country (2021-2032) Figure 47. Brazil Influenza Drugs and Vaccines Sales and Growth Rate (2021-2032) & (Tons) Figure 48. South Africa Influenza Drugs and Vaccines Sales and Growth Rate (2021-2032) & (Tons) Figure 49. Saudi Arabia Influenza Drugs and Vaccines Sales and Growth Rate (2021-2032) & (Tons) Figure 50. Turkey Influenza Drugs and Vaccines Sales and Growth Rate (2021-2032) & (Tons) Figure 51. Argentina Influenza Drugs and Vaccines Sales and Growth Rate (2021-2032) & (Tons) Figure 52. UAE Influenza Drugs and Vaccines Sales and Growth Rate (2021-2032) & (Tons) Figure 53. Egypt Influenza Drugs and Vaccines Sales and Growth Rate (2021-2032) & (Tons) Figure 54. Chile Influenza Drugs and Vaccines Sales and Growth Rate (2021-2032) & (Tons) Figure 55. Global Influenza Drugs and Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Influenza Drugs and Vaccines Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Influenza Drugs and Vaccines Revenue (2021-2032) & (US$ Million) Figure 58. North America Influenza Drugs and Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Influenza Drugs and Vaccines Revenue (2021-2032) & (US$ Million) Figure 60. Europe Influenza Drugs and Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Influenza Drugs and Vaccines Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Influenza Drugs and Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Influenza Drugs and Vaccines Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Influenza Drugs and Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Influenza Drugs and Vaccines Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Influenza Drugs and Vaccines Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Influenza Drugs
  • Influenza Vaccines
Applications
  • Retail Pharmacy
  • Online Pharmacy
  • Hospital Pharmacy
Companies covered
  • CSL
  • Alvogen
  • AstraZeneca
  • BioCryst Pharmaceuticals
  • Bristol Myers Squibb
  • Celgene
  • Emergent Biosolutions
  • GlaxoSmithKline
  • Hulan Bio
  • Protein Sciences Corporation
  • Seqirus
  • Serum Institute of India
  • Viatris
  • Beike Bio
  • Bayer
  • Pfizer
  • Jiangsu GDK
  • Sinovac
  • Eli Lilly
  • Roche
  • Novartis
  • Sanofi
  • Changchun Institute of Biological

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Influenza Drugs and Vaccines Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Influenza Drugs and Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Influenza Drugs and Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Influenza Drugs and Vaccines Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Influenza Drugs and Vaccines Market Dynamics
  1. 2.1 Influenza Drugs and Vaccines Industry Trends
  2. 2.2 Influenza Drugs and Vaccines Industry Drivers
  3. 2.3 Influenza Drugs and Vaccines Industry Opportunities and Challenges
  4. 2.4 Influenza Drugs and Vaccines Industry Restraints
3 Influenza Drugs and Vaccines Market by Manufacturers
  1. 3.1 Global Influenza Drugs and Vaccines Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Influenza Drugs and Vaccines Sales by Manufacturers (2021-2026)
  3. 3.3 Global Influenza Drugs and Vaccines Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Influenza Drugs and Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Influenza Drugs and Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Influenza Drugs and Vaccines Manufacturers, Product Type & Application
  7. 3.7 Global Influenza Drugs and Vaccines Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Influenza Drugs and Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Influenza Drugs and Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Influenza Drugs and Vaccines Tier 1, Tier 2, and Tier 3
4 Influenza Drugs and Vaccines Market by Type
  1. 4.1 Influenza Drugs and Vaccines Type Introduction
  2. 4.1.1 Influenza Drugs
  3. 4.1.2 Influenza Vaccines
  4. 4.2 Global Influenza Drugs and Vaccines Sales by Type
  5. 4.2.1 Global Influenza Drugs and Vaccines Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Influenza Drugs and Vaccines Sales by Type (2021-2032)
  7. 4.2.3 Global Influenza Drugs and Vaccines Sales Market Share by Type (2021-2032)
  8. 4.3 Global Influenza Drugs and Vaccines Revenue by Type
  9. 4.3.1 Global Influenza Drugs and Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Influenza Drugs and Vaccines Revenue by Type (2021-2032)
  11. 4.3.3 Global Influenza Drugs and Vaccines Revenue Market Share by Type (2021-2032)
5 Influenza Drugs and Vaccines Market by Application
  1. 5.1 Influenza Drugs and Vaccines Application Introduction
  2. 5.1.1 Retail Pharmacy
  3. 5.1.2 Online Pharmacy
  4. 5.1.3 Hospital Pharmacy
  5. 5.2 Global Influenza Drugs and Vaccines Sales by Application
  6. 5.2.1 Global Influenza Drugs and Vaccines Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Influenza Drugs and Vaccines Sales by Application (2021-2032)
  8. 5.2.3 Global Influenza Drugs and Vaccines Sales Market Share by Application (2021-2032)
  9. 5.3 Global Influenza Drugs and Vaccines Revenue by Application
  10. 5.3.1 Global Influenza Drugs and Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Influenza Drugs and Vaccines Revenue by Application (2021-2032)
  12. 5.3.3 Global Influenza Drugs and Vaccines Revenue Market Share by Application (2021-2032)
6 Global Influenza Drugs and Vaccines Sales by Region
  1. 6.1 Global Influenza Drugs and Vaccines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Influenza Drugs and Vaccines Sales by Region (2021-2032)
  3. 6.2.1 Global Influenza Drugs and Vaccines Sales by Region (2021-2026)
  4. 6.2.2 Global Influenza Drugs and Vaccines Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Influenza Drugs and Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Influenza Drugs and Vaccines Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Influenza Drugs and Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Influenza Drugs and Vaccines Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Influenza Drugs and Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Influenza Drugs and Vaccines Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Influenza Drugs and Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Influenza Drugs and Vaccines Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Influenza Drugs and Vaccines Revenue by Region
  1. 7.1 Global Influenza Drugs and Vaccines Revenue by Region
  2. 7.1.1 Global Influenza Drugs and Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Influenza Drugs and Vaccines Revenue by Region (2021-2026)
  4. 7.1.3 Global Influenza Drugs and Vaccines Revenue by Region (2027-2032)
  5. 7.1.4 Global Influenza Drugs and Vaccines Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Influenza Drugs and Vaccines Revenue (2021-2032)
  8. 7.2.2 North America Influenza Drugs and Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Influenza Drugs and Vaccines Revenue (2021-2032)
  11. 7.3.2 Europe Influenza Drugs and Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Influenza Drugs and Vaccines Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Influenza Drugs and Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Influenza Drugs and Vaccines Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Influenza Drugs and Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 CSL
  2. 8.1.1 CSL Company Information
  3. 8.1.2 CSL Business Overview
  4. 8.1.3 CSL Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 CSL Influenza Drugs and Vaccines Product Portfolio
  6. 8.1.5 CSL Recent Developments
  7. 8.2 Alvogen
  8. 8.2.1 Alvogen Company Information
  9. 8.2.2 Alvogen Business Overview
  10. 8.2.3 Alvogen Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Alvogen Influenza Drugs and Vaccines Product Portfolio
  12. 8.2.5 Alvogen Recent Developments
  13. 8.3 AstraZeneca
  14. 8.3.1 AstraZeneca Company Information
  15. 8.3.2 AstraZeneca Business Overview
  16. 8.3.3 AstraZeneca Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 AstraZeneca Influenza Drugs and Vaccines Product Portfolio
  18. 8.3.5 AstraZeneca Recent Developments
  19. 8.4 BioCryst Pharmaceuticals
  20. 8.4.1 BioCryst Pharmaceuticals Company Information
  21. 8.4.2 BioCryst Pharmaceuticals Business Overview
  22. 8.4.3 BioCryst Pharmaceuticals Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 BioCryst Pharmaceuticals Influenza Drugs and Vaccines Product Portfolio
  24. 8.4.5 BioCryst Pharmaceuticals Recent Developments
  25. 8.5 Bristol Myers Squibb
  26. 8.5.1 Bristol Myers Squibb Company Information
  27. 8.5.2 Bristol Myers Squibb Business Overview
  28. 8.5.3 Bristol Myers Squibb Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Bristol Myers Squibb Influenza Drugs and Vaccines Product Portfolio
  30. 8.5.5 Bristol Myers Squibb Recent Developments
  31. 8.6 Celgene
  32. 8.6.1 Celgene Company Information
  33. 8.6.2 Celgene Business Overview
  34. 8.6.3 Celgene Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Celgene Influenza Drugs and Vaccines Product Portfolio
  36. 8.6.5 Celgene Recent Developments
  37. 8.7 Emergent Biosolutions
  38. 8.7.1 Emergent Biosolutions Company Information
  39. 8.7.2 Emergent Biosolutions Business Overview
  40. 8.7.3 Emergent Biosolutions Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Emergent Biosolutions Influenza Drugs and Vaccines Product Portfolio
  42. 8.7.5 Emergent Biosolutions Recent Developments
  43. 8.8 GlaxoSmithKline
  44. 8.8.1 GlaxoSmithKline Company Information
  45. 8.8.2 GlaxoSmithKline Business Overview
  46. 8.8.3 GlaxoSmithKline Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 GlaxoSmithKline Influenza Drugs and Vaccines Product Portfolio
  48. 8.8.5 GlaxoSmithKline Recent Developments
  49. 8.9 Hulan Bio
  50. 8.9.1 Hulan Bio Company Information
  51. 8.9.2 Hulan Bio Business Overview
  52. 8.9.3 Hulan Bio Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Hulan Bio Influenza Drugs and Vaccines Product Portfolio
  54. 8.9.5 Hulan Bio Recent Developments
  55. 8.10 Protein Sciences Corporation
  56. 8.10.1 Protein Sciences Corporation Company Information
  57. 8.10.2 Protein Sciences Corporation Business Overview
  58. 8.10.3 Protein Sciences Corporation Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Protein Sciences Corporation Influenza Drugs and Vaccines Product Portfolio
  60. 8.10.5 Protein Sciences Corporation Recent Developments
  61. 8.11 Seqirus
  62. 8.11.1 Seqirus Company Information
  63. 8.11.2 Seqirus Business Overview
  64. 8.11.3 Seqirus Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Seqirus Influenza Drugs and Vaccines Product Portfolio
  66. 8.11.5 Seqirus Recent Developments
  67. 8.12 Serum Institute of India
  68. 8.12.1 Serum Institute of India Company Information
  69. 8.12.2 Serum Institute of India Business Overview
  70. 8.12.3 Serum Institute of India Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Serum Institute of India Influenza Drugs and Vaccines Product Portfolio
  72. 8.12.5 Serum Institute of India Recent Developments
  73. 8.13 Viatris
  74. 8.13.1 Viatris Company Information
  75. 8.13.2 Viatris Business Overview
  76. 8.13.3 Viatris Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Viatris Influenza Drugs and Vaccines Product Portfolio
  78. 8.13.5 Viatris Recent Developments
  79. 8.14 Beike Bio
  80. 8.14.1 Beike Bio Company Information
  81. 8.14.2 Beike Bio Business Overview
  82. 8.14.3 Beike Bio Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Beike Bio Influenza Drugs and Vaccines Product Portfolio
  84. 8.14.5 Beike Bio Recent Developments
  85. 8.15 Bayer
  86. 8.15.1 Bayer Company Information
  87. 8.15.2 Bayer Business Overview
  88. 8.15.3 Bayer Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Bayer Influenza Drugs and Vaccines Product Portfolio
  90. 8.15.5 Bayer Recent Developments
  91. 8.16 Pfizer
  92. 8.16.1 Pfizer Company Information
  93. 8.16.2 Pfizer Business Overview
  94. 8.16.3 Pfizer Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Pfizer Influenza Drugs and Vaccines Product Portfolio
  96. 8.16.5 Pfizer Recent Developments
  97. 8.17 Jiangsu GDK
  98. 8.17.1 Jiangsu GDK Company Information
  99. 8.17.2 Jiangsu GDK Business Overview
  100. 8.17.3 Jiangsu GDK Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Jiangsu GDK Influenza Drugs and Vaccines Product Portfolio
  102. 8.17.5 Jiangsu GDK Recent Developments
  103. 8.18 Sinovac
  104. 8.18.1 Sinovac Company Information
  105. 8.18.2 Sinovac Business Overview
  106. 8.18.3 Sinovac Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Sinovac Influenza Drugs and Vaccines Product Portfolio
  108. 8.18.5 Sinovac Recent Developments
  109. 8.19 Eli Lilly
  110. 8.19.1 Eli Lilly Company Information
  111. 8.19.2 Eli Lilly Business Overview
  112. 8.19.3 Eli Lilly Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Eli Lilly Influenza Drugs and Vaccines Product Portfolio
  114. 8.19.5 Eli Lilly Recent Developments
  115. 8.20 Roche
  116. 8.20.1 Roche Company Information
  117. 8.20.2 Roche Business Overview
  118. 8.20.3 Roche Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Roche Influenza Drugs and Vaccines Product Portfolio
  120. 8.20.5 Roche Recent Developments
  121. 8.21 Novartis
  122. 8.21.1 Novartis Company Information
  123. 8.21.2 Novartis Business Overview
  124. 8.21.3 Novartis Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Novartis Influenza Drugs and Vaccines Product Portfolio
  126. 8.21.5 Novartis Recent Developments
  127. 8.22 Sanofi
  128. 8.22.1 Sanofi Company Information
  129. 8.22.2 Sanofi Business Overview
  130. 8.22.3 Sanofi Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Sanofi Influenza Drugs and Vaccines Product Portfolio
  132. 8.22.5 Sanofi Recent Developments
  133. 8.23 Changchun Institute of Biological
  134. 8.23.1 Changchun Institute of Biological Company Information
  135. 8.23.2 Changchun Institute of Biological Business Overview
  136. 8.23.3 Changchun Institute of Biological Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Changchun Institute of Biological Influenza Drugs and Vaccines Product Portfolio
  138. 8.23.5 Changchun Institute of Biological Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Influenza Drugs and Vaccines Value Chain Analysis
  2. 9.1.1 Influenza Drugs and Vaccines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Influenza Drugs and Vaccines Production Mode & Process
  6. 9.2 Influenza Drugs and Vaccines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Influenza Drugs and Vaccines Distributors
  9. 9.2.3 Influenza Drugs and Vaccines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst